Mrs. Sunaina Kitkasetpaisan general manager Zuellig Pharma Company Limited revealed that Food and Drug Administration (FDA) has increased approval for the use of the COVID-19 vaccine Moderna Among adolescents aged 12-17 years in Thailand, the vaccination pattern is the same as for the adult vaccination, which is 2 injections, with the second injection 28 days away from the first dose. -19 Moderna for young people It is considered to increase the potential of the COVID-19 vaccine. that Thailand can use to combat the epidemic situation
“The Company is very pleased that FDA approved the use of the COVID-19 vaccine Moderna for young people in order to have a shield against the corona virus Especially in a situation where the delta strain continues to be highly contagious… if we can support vaccination to cover more people, how much? The faster the group immunity will be driven. And it will also help the country return to normal faster in the end.” Mrs. Sunaina said
However, in May 2021, Moderna announced the results of a Phase 2/3 clinical study of the COVID-19 Moderna vaccine in adolescents (Phase 2/3 TeenCOVE study). Immunization success Equivalent to vaccine immunization among adults Two doses of the Covid-19 Moderna vaccine were shown to be 100% effective in preventing symptomatic infection among adolescents aged 12-17.
The safety and response to vaccines were comparable to those seen in the adult Phase 3 clinical trial (Phase 3 COVE study). continually and continues to monitor research results from independent safety monitoring committees. These data are subject to change depending on the results of additional data collection.
